These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18563383)

  • 1. A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.
    Pearson T; Shultz LD; Lief J; Burzenski L; Gott B; Chase T; Foreman O; Rossini AA; Bottino R; Trucco M; Greiner DL
    Diabetologia; 2008 Aug; 51(8):1449-56. PubMed ID: 18563383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.
    Brehm MA; Bortell R; Diiorio P; Leif J; Laning J; Cuthbert A; Yang C; Herlihy M; Burzenski L; Gott B; Foreman O; Powers AC; Greiner DL; Shultz LD
    Diabetes; 2010 Sep; 59(9):2265-70. PubMed ID: 20570944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia-induced proliferation of adult human beta cells engrafted into spontaneously diabetic immunodeficient NOD-Rag1null IL2rγnull Ins2Akita mice.
    Diiorio P; Jurczyk A; Yang C; Racki WJ; Brehm MA; Atkinson MA; Powers AC; Shultz LD; Greiner DL; Bortell R
    Pancreas; 2011 Oct; 40(7):1147-9. PubMed ID: 21926555
    [No Abstract]   [Full Text] [Related]  

  • 4. New mouse model to study islet transplantation in insulin-dependent diabetes mellitus.
    Mathews CE; Langley SH; Leiter EH
    Transplantation; 2002 Apr; 73(8):1333-6. PubMed ID: 11981430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull mice.
    Xiao F; Ma L; Zhao M; Huang G; Mirenda V; Dorling A; Lechler R; Lombardi G
    PLoS One; 2014; 9(3):e90387. PubMed ID: 24594640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation.
    Abualhassan N; Sapozhnikov L; Pawlick RL; Kahana M; Pepper AR; Bruni A; Gala-Lopez B; Kin T; Mitrani E; Shapiro AM
    PLoS One; 2016; 11(5):e0156053. PubMed ID: 27227978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets.
    Udayasankar J; Kodama K; Hull RL; Zraika S; Aston-Mourney K; Subramanian SL; Tong J; Faulenbach MV; Vidal J; Kahn SE
    Diabetologia; 2009 Jan; 52(1):145-53. PubMed ID: 19002432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes.
    Hua XF; Wang YW; Tang YX; Yu SQ; Jin SH; Meng XM; Li HF; Liu FJ; Sun Q; Wang HY; Li JY
    PLoS One; 2014; 9(7):e102198. PubMed ID: 25009980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
    Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNA-150-5p is associated with immune-mediated early β-cell loss in a humanized mouse model.
    Roat R; Hossain MM; Christopherson J; Free C; Guay C; Regazzi R; Guo Z
    Xenotransplantation; 2019 Mar; 26(2):e12474. PubMed ID: 30461074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.
    Abdulreda MH; Molano RD; Faleo G; Lopez-Cabezas M; Shishido A; Ulissi U; Fotino C; Hernandez LF; Tschiggfrie A; Aldrich VR; Tamayo-Garcia A; Bayer AS; Ricordi C; Caicedo A; Buchwald P; Pileggi A; Berggren PO
    Diabetologia; 2019 Jul; 62(7):1237-1250. PubMed ID: 31087105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice.
    Rao P; Roccisana J; Takane KK; Bottino R; Zhao A; Trucco M; García-Ocaña A
    Diabetes; 2005 Jun; 54(6):1664-75. PubMed ID: 15919787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal relationship of beta- and non-beta-cells not needed for successful islet transplantation.
    King AJ; Fernandes JR; Hollister-Lock J; Nienaber CE; Bonner-Weir S; Weir GC
    Diabetes; 2007 Sep; 56(9):2312-8. PubMed ID: 17563059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
    Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
    Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
    Shultz LD; Lang PA; Christianson SW; Gott B; Lyons B; Umeda S; Leiter E; Hesselton R; Wagar EJ; Leif JH; Kollet O; Lapidot T; Greiner DL
    J Immunol; 2000 Mar; 164(5):2496-507. PubMed ID: 10679087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of hyperglycemia on the primary function of allogeneic islet transplants.
    Makhlouf L; Duvivier-Kali VF; Bonner-Weir S; Dieperink H; Weir GC; Sayegh MH
    Transplantation; 2003 Aug; 76(4):657-64. PubMed ID: 12973104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice.
    Suarez-Pinzon WL; Lakey JR; Rabinovitch A
    Cell Transplant; 2008; 17(6):631-40. PubMed ID: 18819251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice.
    Levitt HE; Cyphert TJ; Pascoe JL; Hollern DA; Abraham N; Lundell RJ; Rosa T; Romano LC; Zou B; O'Donnell CP; Stewart AF; Garcia-Ocaña A; Alonso LC
    Diabetologia; 2011 Mar; 54(3):572-82. PubMed ID: 20936253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.